Technical Analysis for CODX - Co-Diagnostics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Support | Bullish | 2.46% | |
| Gapped Down | Weakness | 2.46% | |
| Inside Day | Range Contraction | -0.79% | |
| Above Upper BB | Strength | -0.79% | |
| Upper Bollinger Band Touch | Strength | -0.79% | |
| Gapped Down | Weakness | -0.79% | |
| Stochastic Reached Overbought | Strength | -0.79% | |
| Overbought Stochastic | Strength | -0.79% | |
| Up 3 Days in a Row | Strength | -0.79% | |
| Up 4 Days in a Row | Strength | -0.79% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | about 4 hours ago |
| 10 DMA Support | about 5 hours ago |
| Rose Above Previous Day's High | about 5 hours ago |
| Rose Above Upper Bollinger Band | about 5 hours ago |
| Up 3% | about 5 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/09/2024
Co-Diagnostics, Inc. Description
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Clinical Medicine Disease Acid Hepatitis B Medical Test Diagnostic Tests Molecular Diagnostics Genetic Diseases Immunodeficiency Malaria Organisms Diagnostic Equipment Polymerase Chain Reaction Tuberculosis Ortho Clinical Diagnostics Dengue Zika Dengue Fever
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.88 |
| 52 Week Low | 0.975 |
| Average Volume | 58,277 |
| 200-Day Moving Average | 1.20 |
| 50-Day Moving Average | 1.16 |
| 20-Day Moving Average | 1.18 |
| 10-Day Moving Average | 1.19 |
| Average True Range | 0.07 |
| RSI (14) | 56.14 |
| ADX | 14.94 |
| +DI | 17.15 |
| -DI | 13.08 |
| Chandelier Exit (Long, 3 ATRs) | 1.10 |
| Chandelier Exit (Short, 3 ATRs) | 1.29 |
| Upper Bollinger Bands | 1.26 |
| Lower Bollinger Band | 1.10 |
| Percent B (%b) | 0.74 |
| BandWidth | 13.81 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.01 |
| MACD Histogram | 0.0093 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.31 | ||||
| Resistance 3 (R3) | 1.31 | 1.28 | 1.30 | ||
| Resistance 2 (R2) | 1.28 | 1.26 | 1.28 | 1.29 | |
| Resistance 1 (R1) | 1.25 | 1.24 | 1.24 | 1.25 | 1.28 |
| Pivot Point | 1.22 | 1.22 | 1.21 | 1.22 | 1.22 |
| Support 1 (S1) | 1.19 | 1.20 | 1.18 | 1.19 | 1.16 |
| Support 2 (S2) | 1.16 | 1.18 | 1.16 | 1.15 | |
| Support 3 (S3) | 1.13 | 1.16 | 1.15 | ||
| Support 4 (S4) | 1.13 |
